We are a branded IPR-based pharmaceutical Company focusing on frontier markets...
Our purpose is to bring high-quality every-day medicines within the reach of populations...
Over the years, we have geared ourselves to create a meaningful business ...
Meet our leadership team that guides us
through all our business decisions...
Policies & disclosures
At Balaxi, our business strategies are responsible for creating a portfolio
We focus on bringing essential medicines within the reach of populations
At Balaxi, we have a comprehensive portfolio consisting of over 300
Our current established markets are Angola, Guatemala, and Dominican
Know how we manage distributions
across our markets...
Locate our offices across
Be a part of Balaxi and grow
Spreading awareness of our products
through our promotional campaigns...
Know about us in detail through our
At Balaxi, we constantly create a work environment that encourages ...
At Balaxi, we understand the importance of healthy employee relations...
Join us and become a Balaxite...
Balaxi Pharmaceutical Limited (BPL) commenced pharmaceutical business in 2003 by supplying
white labelled products to customers in Africa.
The Company’s headquarters are located in Hyderabad, Telangana.
As of H1FY21, the revenue mix indicates – Pharmaceutical: 63%, Ancillary: 27%, and Branded
Consumer Products: 10%
The Company’s Common Stock is traded on the National Stock Exchange with the
Balaxi’s fiscal year ends on March 31st.
The Company was listed on NSE in 2015 as ‘The Anandam Rubber Company Ltd’. Since it was not
an IPO, the listing price cannot be mentioned. Balaxi had acquired the shares of The Anandam
No. The company never had a stock split.
Yes. Balaxi reports its quarterly results on Stock Exchange and Company website
The Annual Report of the Company is published on its official website every financial year.
No. The company has not paid any dividend.
No. The company doesn’t offer this.
The 77th AGM was held on Friday, September 11, 2020 at 09.00 AM (IST). Due to public health
concerns surrounding the outbreak of the Coronavirus (COVID-19) and to prioritise the health
and well-being of its employees, shareholders and other community members, the 2020 Annual
Meeting of Shareholders was held in a virtual meeting format only.
This information has also been made available on the Company’s website, at
The information and details with respect to its next AGM will be released on the Stock Exchange
Announcements as well as its website.
Balaxi’s annual and quarterly financial results and other information are available on this
website. You can automatically receive updates by clicking on e-alerts on the “Investors
Overview” page of this website.
Please direct your communications regarding individual stock records, address changes or
dividend payments to: Balaxi Pharmaceutical Limited
Plot No.409, H. No: 8-2-293,
MAPS Towers, 3rd Floor,
Phase-III, Road No: 81, Jubilee Hills,
Hyderabad, Telangana, India, 500 096
Or call: +91 40 2355-5300
Or write to us at:[email protected]
P.MURALI & Co. is the independent auditor of Balaxi Pharmaceuticals.
You can know about the Company’s upcoming investor events on the “Investors” section of this
website. You can also write to us at: [email protected] to know more about it.
Yes. We have an in-depth investor presentation that tells you about us, our business model, our
distribution network, and performance, amongst other details. You can access the presentation
on the “Investors” section of this website.